Please login to the form below

Not currently logged in
Email:
Password:

MediCity names David Browning as director

Will head the UK collaboration between Alliance Boots and Nottingham-based biocluster BioCity

MediCity David Browning A new collaboration between pharmacy chain Alliance Boots and the Nottingham-based biocluster BioCity took a step forward this week with the appointment of David Browning as director.

MediCity is a subsidiary of BioCity and is based on the Alliance Boots site within the Nottingham Enterprise Zone. It aims to provide start-ups in the health and wellness sector with office and laboratory space.

Browning joins the new venture from healthcare consultancy Paragreen Associates where he served as managing director.

His past experience in healthcare includes a VP role within the healthcare business of Philips and four years as CEO of nanotechnology specialist Oxonica Healthcare.

During this period in charge of Oxonica, Browning worked with Alliance Boots to launch Optisol, an active ingredient in suncare products.

His new role sees him once again working with Alliance Boots, with the company contributing access to innovation and product development knowledge and supply chain expertise to companies involved in MediCity.

Browning's first task in charge is to oversee the refurbishment and population of MediCity's base in Nottingham, before leading the call for tenants to take up space.

“I grew up in the East Midlands and I am looking forward to working with talented innovators of new clinical and consumer products,” he said.

“We will draw on a network of business, financial and technical experts, as well as Alliance Boots experience, to help them commercialise their ideas.”

16th October 2013

From: Research

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Havas Lynx Group

We are the Havas Lynx Group. Devoted to fresh thinking. Changing the way the world does healthcare communications for the...

Latest intelligence

Precision paediatrics: Treating patients with CAR-T
Dr Stuart Adams specialises in using T-cell therapy to treat paediatric patients at Great Ormond Street Hospital. Here, he explains what it was like to develop and deliver a groundbreaking...
What does it mean to be an agile organisation
We spoke with Philip Atkinson to learn how healthcare and pharmaceutical companies can rapidly respond to changes in the market....
Battling breast cancer with precision medicine (Part 2)
Dr Mark Moasser treated breast cancer survivor Laura Holmes-Haddad (interviewed in part one) with an innovative precision medicine, which at the time was yet to be approved. Here he gives...

Infographics